A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: a TAX327 study analysis. [electronic resource]
Producer: 20080122Description: 6396-403 p. digitalISSN:- 1078-0432
- Algorithms
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Docetaxel
- Female
- Humans
- Kinetics
- Male
- Mitoxantrone -- administration & dosage
- Neoplasm Metastasis
- Nomograms
- Prednisone -- administration & dosage
- Prognosis
- Proportional Hazards Models
- Prostate-Specific Antigen -- metabolism
- Prostatic Neoplasms -- diagnosis
- Regression Analysis
- Survival Analysis
- Taxoids -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.